Escalating Doses of Buprenorphine for the Treatment of Buprenorphine-Induced Opioid Withdrawal
- PMID: 40225488
- PMCID: PMC11993309
- DOI: 10.7759/cureus.80527
Escalating Doses of Buprenorphine for the Treatment of Buprenorphine-Induced Opioid Withdrawal
Abstract
This report outlines a case of opiate withdrawal that occurred following the initiation of treatment for opioid use disorder (OUD) with buprenorphine. Buprenorphine is a novel drug that is used in the treatment of OUD and is incredibly effective in doing so. However, a rare and paradoxical effect can occur when treatment is initiated with buprenorphine, where the drug, due to its unusual mechanism of action, precipitates withdrawal. Most of the time, withdrawal can be treated with supportive therapy. However, there is growing evidence in the literature that withdrawals precipitated by buprenorphine can and should be treated with increased doses of buprenorphine. This case is an example of this exact phenomenon. In this case, our patient had a longstanding OUD, particularly fentanyl use, which was treated the day of presentation with the initiation of buprenorphine. She later presented to the emergency department in opioid withdrawal, which was treated with adjunct therapy that did not aid in the resolution of symptoms. Finally, escalating doses of buprenorphine were administered, which resolved the patient's symptoms, highlighting another case to be added to the growing evidence that opioid withdrawals precipitated by buprenorphine can and should be treated with escalating doses of buprenorphine.
Keywords: buprenorphine; opiate withdrawal; opioid withdrawals; pain management; suboxone.
Copyright © 2025, Laxton et al.
Conflict of interest statement
Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Similar articles
-
Buprenorphine initiation and rates of associated precipitated withdrawal in patients with fentanyl use in an urban emergency department.Am J Emerg Med. 2025 Feb;88:152-155. doi: 10.1016/j.ajem.2024.11.079. Epub 2024 Nov 25. Am J Emerg Med. 2025. PMID: 39626454
-
Case Report: Buprenorphine-precipitated fentanyl withdrawal treated with high-dose buprenorphine.F1000Res. 2023 Aug 10;11:487. doi: 10.12688/f1000research.120821.2. eCollection 2022. F1000Res. 2023. PMID: 37767082 Free PMC article.
-
Buprenorphine precipitated opioid withdrawal: Prevention and management in the ED setting.Am J Emerg Med. 2022 Aug;58:22-26. doi: 10.1016/j.ajem.2022.05.013. Epub 2022 May 14. Am J Emerg Med. 2022. PMID: 35623179 Review.
-
Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.Hosp Pract (1995). 2022 Oct;50(4):251-258. doi: 10.1080/21548331.2022.2102776. Epub 2022 Jul 22. Hosp Pract (1995). 2022. PMID: 35837678 Review.
-
Successful buprenorphine transition while overlapping with a full opioid agonist to treat chronic pain: a case report.J Osteopath Med. 2022 Oct 25;123(1):1-5. doi: 10.1515/jom-2022-0075. eCollection 2023 Jan 1. J Osteopath Med. 2022. PMID: 36282967
References
-
- A case of buprenorphine-precipitated withdrawal managed with high-dose buprenorphine. Quattlebaum TH, Kiyokawa M, Murata KA. https://academic.oup.com/fampra/article/39/2/292/6309967 Fam Pract. 2022;24:292–294. - PubMed
-
- Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Ma J, Bao YP, Wang RJ, et al. Mol Psychiatry. 2019;24:1868–1883. - PubMed
-
- Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths - 27 states, 2013-2014. Gladden RM, Martinez P, Seth P. MMWR Morb Mortal Wkly Rep. 2016;65:837–843. - PubMed
-
- Opioid withdrawal precipitated by long-acting antagonists. Kunzler NM, Wightman RS, Nelson LS. J Emerg Med. 2020;58:245–253. - PubMed
Publication types
LinkOut - more resources
Full Text Sources